Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women

• Main Authors: Susanne K. Kjaer (Author), Thea E. Hetland Falkenthal (Author), Karin Sundström (Author), Christian Munk (Author), Tina Sture (Author), Oliver Bautista (Author), Sonali Rawat (Author), Alain Luxembourg (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

A pivotal study in women aged 16-26 years demonstrated that the nine-valent human papillomavirus (9vHPV) vaccine was efficacious against high-grade cervical dysplasia related to the HPV types covered by the vaccine. To evaluate whether effectiveness remains above 90% for up to 14 years post-vaccinat...